Mast cell leukemia surgery: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]], or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]], or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | ||
==Surgery== | ==Surgery== | ||
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]], or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]], or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} | ||
Revision as of 20:42, 1 December 2015
|
Mast cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell leukemia surgery On the Web |
|
American Roentgen Ray Society Images of Mast cell leukemia surgery |
|
Risk calculators and risk factors for Mast cell leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy, or bone marrow transplantation may be required in certain cases.[1]
Surgery
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy, or bone marrow transplantation may be required in certain cases.[1]